Fingerprint
Dive into the research topics of 'Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically